Craig Hallum initiated coverage on SelectQuote with a new price target
$SLQT
Specialty Insurers
Finance
Craig Hallum initiated coverage of SelectQuote with a rating of Buy and set a new price target of $4.50
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/30/2024 | $4.50 | Buy | Craig Hallum |
| 2/29/2024 | $5.00 | Outperform | Noble Capital Markets |
| 4/1/2022 | $4.00 | Neutral | Credit Suisse |
| 2/8/2022 | $9.00 → $5.00 | Equal Weight | Barclays |
| 2/8/2022 | $13.00 → $3.00 | Sector Perform | RBC Capital |
| 2/8/2022 | $20.00 → $4.00 | Overweight → Neutral | Piper Sandler |
| 2/8/2022 | $14.00 → $4.00 | Outperform → Neutral | Credit Suisse |
| 1/18/2022 | $21.00 → $9.00 | Overweight → Equal Weight | Barclays |
8-K - SelectQuote, Inc. (0001794783) (Filer)
S-8 - SelectQuote, Inc. (0001794783) (Filer)
8-K/A - SelectQuote, Inc. (0001794783) (Filer)
First Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $292.3 million Net loss of $44.5 million Adjusted EBITDA* of $(1.7) million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.425 billion to $1.525 billion Net income (loss) expected in a range of $(59) million to $3 million Adjusted EBITDA* expected in a range of $100 million to $130 million First Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $92.9 million Adjusted EBITDA* of $7.7 million Approved Medicare Advantage policies of 91,680 Healthcare Services Revenue of $155.7 million Adjusted EBITDA* of $4.9 million 86,521 SelectRx members Life
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its first quarter 2025 financial results before market open on Monday, November 4, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (November 4, 2024) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://registrations.events/direct/Q4I1559258472 After registering, a confirmation will be sent via email, including dial in details and unique conference call codes for entry. Re
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly-growing Healthcare Services platform, today announced the completion of a $100 million securitization transaction on October 15, 2024. Securitization provides advanced financing against the Company's expected collections for policies previously sold. The Company's receivables totaled approximately $1 billion as of June 30, 2024, and only a portion of the total receivables balance was securitized in this transaction. The Company will use the proceeds from this first securitization to pay down a portion of its outstanding term debt. The new securitized debt offers a materially lower cos
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
Raising Fiscal Year 2024 Guidance Ranges: Revenue expected in a range of $1.25 billion to $1.3 billion vs prior range of $1.23 billion to $1.3 billion Net loss expected in a range of $34 million to $21 million vs prior range of $45 million to $22 million Adjusted EBITDA* expected in a range of $100 million to $110 million vs prior range of $90 million to $105 million
SelectQuote (NYSE:SLQT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of $376.400 million which beat the analyst consensus estimate of $339.700 million by 10.80 percent. This is a 25.72 percent increase over sales of $299.398 million the same period last year.
Craig Hallum initiated coverage of SelectQuote with a rating of Buy and set a new price target of $4.50
Noble Capital Markets initiated coverage of SelectQuote with a rating of Outperform and set a new price target of $5.00
Credit Suisse resumed coverage of SelectQuote with a rating of Neutral and set a new price target of $4.00
First Quarter of Fiscal Year 2025 – Consolidated Earnings Highlights Revenue of $292.3 million Net loss of $44.5 million Adjusted EBITDA* of $(1.7) million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.425 billion to $1.525 billion Net income (loss) expected in a range of $(59) million to $3 million Adjusted EBITDA* expected in a range of $100 million to $130 million First Quarter Fiscal Year 2025 – Segment Highlights Senior Revenue of $92.9 million Adjusted EBITDA* of $7.7 million Approved Medicare Advantage policies of 91,680 Healthcare Services Revenue of $155.7 million Adjusted EBITDA* of $4.9 million 86,521 SelectRx members Life
SelectQuote, Inc. (NYSE:SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its first quarter 2025 financial results before market open on Monday, November 4, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (November 4, 2024) at 8:30 am ET to discuss the results. To register for this conference call, please use this link: https://registrations.events/direct/Q4I1559258472 After registering, a confirmation will be sent via email, including dial in details and unique conference call codes for entry. Re
Fourth Quarter of Fiscal Year 2024 – Consolidated Earnings Highlights Revenue of $307.2 million Net loss of $31.0 million Adjusted EBITDA* of $14.4 million Fiscal Year 2025 Guidance Ranges: Revenue expected in a range of $1.4 billion to $1.5 billion Net loss expected in a range of $42 million to $6 million Adjusted EBITDA* expected in a range of $90 million to $120 million Fourth Quarter Fiscal Year 2024 – Segment Highlights Senior Revenue of $114.1 million Adjusted EBITDA* of $27.9 million Approved Medicare Advantage policies of 107,272 Healthcare Services Revenue of $145.2 million Adjusted EBITDA* of $0.9 million Approximately 82,000 SelectRx members Life
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
4 - SelectQuote, Inc. (0001794783) (Issuer)
Clement has served as Interim CFO since May 2022 SelectQuote, Inc. (NYSE:SLQT) today announced that the Board of Directors appointed Ryan Clement, SVP of Financial Planning & Analysis, to serve as the company's Chief Financial Officer. Clement was named interim CFO in May 2022. CEO Tim Danker commented, "Over the last year, Ryan has excelled as our Interim CFO and has demonstrated both the financial acumen and leadership qualities we are looking for in the company's next permanent CFO. Ryan has played a critical role in our strategic redesign that has vastly improved SelectQuote's operating results and financial stability and positions the company to execute on our objectives in the futur
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)
SC 13G/A - SelectQuote, Inc. (0001794783) (Subject)